Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)()

Although recent progress in understanding the biology and optimizing the treatment of acute lymphoblastic leukemia (ALL) has improved cure rates of childhood ALL to nearly 90%, the cure rate in adult ALL remains less than 50%. The poor prognosis in adult ALL has in part been attributed to larger pro...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transl Oncol
Hoofdauteurs: Mutonga, Martin, Tamura, Kenji, Malnassy, Gregory, Fulton, Noreen, de Albuquerque, Amanda, Hamamoto, Ryuji, Stock, Wendy, Nakamura, Yusuke, Alachkar, Houda
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Neoplasia Press 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631083/
https://ncbi.nlm.nih.gov/pubmed/26500027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2015.07.003
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items